boric acid has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cimpean, A; Ciofrangeanu, CM; Ciubar, R; Iordachescu, D; Mitran, V; Scorei, R | 1 |
| Agrawal, SG; Gribben, JG; Jia, L; Liu, FT; Movasaghi, Z; Newland, AC; Rehman, IU; Wyatt, PB | 1 |
2 other study(ies) available for boric acid and cytochrome c-t
| Article | Year |
|---|---|
Comparative effects of boric acid and calcium fructoborate on breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Borates; Boric Acids; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Dose-Response Relationship, Drug; Female; Fructose; Humans; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2008 |
Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Boric Acids; Boronic Acids; Bortezomib; Cell Line, Transformed; Cell Line, Tumor; Cytochromes c; Diet; Flavonoids; Free Radical Scavengers; Humans; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Multiple Myeloma; Protease Inhibitors; Pyrazines; Quercetin | 2008 |